Four Sample Of Piecan Pharma Fail In Quality Tests

Jaipur: Four samples of cefixime antibiotics, produced by the same pharma company that was raided by FDCA in Gujarat, have failed the quality test in Rajasthan.

The seized samples of the antibiotic had no cefixime in them. Piecan Pharma, the drug manufacturer, was raided by FDCA in Gujarat during a crackdown on spurious drugs. The same drugs, also being sold in Rajasthan, were seized by FDCA and Rs 6 lakh worth of the spurious antibiotic was recovered. The state team has informed its Gujarat counterparts.

“The cefixime tablets manufactured by Piecan Pharma failed quality test. We found that it did not contain cefixime content in it,” said Ajay Phatak, drug controller (I), health department. Phatak said, “Spurious drugs racket was busted in Gujarat where action against Piecan Pharma was taken.”

The state’s FSDC also conducted searches. “We found these drugs stored at 13 places. We have seized the stock of these drugs which costs around Rs 6-lakh,” said Phatak.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?